...
首页> 外文期刊>International journal of clinical pharmacology and therapeutics >Patterns of potassium wasting in response to stepwise combinations of diuretics in nephrotic syndrome.
【24h】

Patterns of potassium wasting in response to stepwise combinations of diuretics in nephrotic syndrome.

机译:肾病综合征中利尿剂逐步联合使用对钾的消耗方式。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To study the urinary potassium wasting patterns when the decreasing effectiveness of diuretics during repeated administrations are counterbalanced by stepwise increases of doses and combinations of them. PATIENTS: Eleven patients with renal edema. Seven patients suffered from advanced nephrotic syndrome and 4 patients were "forme fruste". METHODS: Urinary excretions and serum levels of potassium, sodium, creatinine, osmoles were determined; specific renal functions, glomerular filtration rate (GFR) fractional excretion of potassium (FE(K)), transtubular potassium gradient (TTKG) and free water reabsorption (TcH2O) were calculated. Nine different intervention-induced changes were followed daily: furosemide (FSD) alone, FSD with chlorthalidone (CTN), "low dose" and "high dose" potassium sparing drugs (PSD), FSD with CTN and "low dose" or "high dose" PSD, and "no drug" as well as "postdiuretic" periods with or without PSD. RESULTS: TTKG significantly decreased in response to FSD. It elevated during FSD with CTN, but remained lower than the baseline. The normal correlation between urinary potassium excretion (UKV) and TTKG became distorted under FSD. UKV and FE(K) were slightly increased by FSD and more markedly when given FSD together with CTN, probably because "distal volume flow" was elevated. In the "postdiuretic" periods TTKG increased, but this was reversed by PSD. In response to PSD, TTKG and UKV decreased, but both were elevated when combining with FSD + CTN. CONCLUSIONS: FSD caused relatively small potassium loss, because the enhanced "distal volume flow" was counterbalanced by a decrease of TTKG. FSD may have had a potassium secretion inhibitory influence as well. Potassium loss and TTKG were enhanced during coadministration of CTN, and decreased by PSD. "Postdiuretic rebound" increase of TTKG was reversed by PSD.
机译:目的:研究逐步增加剂量及其组合来抵消利尿剂在重复给药过程中的有效性下降所引起的尿钾浪费模式。患者:11例肾性水肿患者。患有晚期肾病综合征的患者有7例,“甲壳瘤”为4例。方法:测定尿中排泄物和血清钾,钠,肌酐,渗透压的浓度;计算特定的肾功能,肾小球滤过率(GFR),钾的排泄分数(FE(K)),肾小管的钾梯度(TTKG)和自由水重吸收(TcH2O)。每天跟踪9种不同的干预措施引起的变化:单独使用速尿(FSD),使用氯噻酮(CTN)的FSD,“低剂量”和“高剂量”的钾节约药物(PSD),使用CTN和“低剂量”或“高剂量”的FSD剂量” PSD,以及“有无PSD”的“无药”期和“利尿后”期。结果:TTSD对FSD有显着降低。在使用CTN的FSD期间升高,但仍低于基线。在FSD下,尿钾排泄(UKV)和TTKG之间的正常相关性被扭曲了。 FSD使UKV和FE(K)略有增加,与CTN一起给予FSD时,UKV和FE(K)更为明显,这可能是因为“远处的体积流量”增加了。在“利尿后”时期,TTKG增加,但是PSD逆转了这一趋势。响应PSD,TTKG和UKV降低,但与FSD + CTN结合时两者均升高。结论:FSD导致钾的流失相对较小,因为增加的“远端容积流量”被TTKG的降低所抵消。 FSD也可能具有钾分泌抑制作用。 CTN并用时钾流失和TTKG升高,而PSD则降低。 PSD逆转了TTKG的“利尿后反弹”增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号